Ascletis Announces Positive Preclinical Data for Oral Obesity Peptide Pipeline

Ascletis reported positive preclinical data for its once-weekly oral peptide pipeline for obesity treatment. The company says the pipeline covers four validated targets and includes multiple fixed-dose combinations.